luteinizing hormone-releasing hormone agonist

LH-RH agonist Endocrinology Any substance that simulates LH-RH which, with time, result in a ↓ sex hormone secretion. See H-RH.

Mentioned in

prostate cancer

References in periodicals archive

Testosterone breakthrough during luteinizing hormone-releasing hormone agonist therapy impacts biochemical disease progression: Fact or myth?

Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: Does it happen and does it matter?

Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians

3.: Kaplan Meier curves of proportion of patients in the short-acting luteinizing hormone-releasing hormone agonist (LHRH-A) treatment arm with testosterone recovery to baseline level in men < 65 years or (n=12) or [greater than or equal to] 65 years of age (n=12).

Randomized study evaluating testosterone recovery using short-versus long-acting luteinizing hormone releasing hormone agonists

When luteinizing hormone-releasing hormone agonists are first prescribed, there is a temporary flare of testosterone production that may last for 30 days before testicular testosterone production shuts down.

Vindication

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.